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In addition to HLA associated genetic predisposition, the role of In addition, PTPN2, a candidate gene for T1D is a negative regulator
exogenous factors in the development of type 1 diabetes (T1D) is well
admitted. Since many decades, accumulating evidence strongly has
supported an association between enteroviruses (EV) and T1D (Hober
and Sauter, 2010). Moreover, the potential mechanisms underlying
this enteroviral pathogenesis are getting better understood, and may
also be linked to background susceptibility.
Beta cell destruction/dysfunction in T1D would result from an
autoimmune process (Roep and Tree, 2014) and the role of EV in the
scenario should not be thought as a massive lytic replication in islets.
The implication of the virus relies on the immune response, and
especially the production of type 1 interferons (IFNs) and other pro-
inﬂammatory cytokines. Indeed, the terms of the interaction between
the virus and the innate immune system determine the susceptibility
to this EV-mediated autoimmune diabetes, and could justify why such
infection do not trigger T1D in every patient. The scenario leading to
the disease is thought to include the production of signiﬁcant amounts
of IFNs, through activation of pathogen recognition receptors (PRRs).
This inﬂammatory environment contributes to the initiation of autoim-
mune destruction of beta cells.
Candidate genes for T1D have been identiﬁed by genome-wide
association studies. These genes may be involved in (i) innate immune
response to infectious agents such as EV, (ii) modulation of antigen
presentation and expansion of self-reactive cells or (iii) regulation of
beta cell apoptosis (Concannon et al., 2009; Santin and Eizirik, 2013).
Innate immune system gene polymorphisms that are speciﬁcally
related to response to viruses are very attractive to understand the
early events in the enteroviral pathogenesis of T1D. This may cover
molecules and pathways involved in virus recognition and IFN
production as well as IFN-dependent downstream signaling and antivi-
ral responses.
At PRR signaling level, some rare polymorphisms of IFIH1 (orMDA5)
were shown to be associated to a reduced risk of T1D (Nejentsev et al.,
2009). MDA5 is a well-known intracellular sensor for EV. Protective
variants displaying reduced MDA5 expression are associated with a
lesser response to viral infection and reduced inﬂammation in islets
(Lincez et al., 2015).DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.05.004.
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pathway in beta cells and modulate IFN-induced beta cell apoptosis.
Polymorphisms leading to a reduced expression of PTPN2 (T1D risk
variant) could predispose β-cells to increased apoptosis following type
1 interferon induced by a viral infection (Colli et al., 2010).
Type 1 IFN signaling pathway also includes TYK2, another candidate
gene associated with T1D (Wallace et al., 2010). Such association was
already described with other autoimmune diseases like systemic lupus
erythematosus or inﬂammatory bowel diseases. It was earlier shown
that mice with natural mutation within this gene or KO models were
more susceptible to infection and displayed an alteration of the
response to IFNs and others pro-inﬂammatory cytokines. More recently
this gene was clearly linked to the susceptibility of mice to a rapidly-
progressing hyperglycemia induced by encephalomyocarditis virus
(EMCV) (Izumi et al., 2015).
In their study, Nagafuchi et al. (2015) investigated in humans the
link between TYK2 polymorphisms and the risk for diabetes. The
authors identiﬁed a TYK2 promoter haplotype in patients with
suspected viral infection at T1D onset. Interestingly, this variant was
associated with increased risk of both type 1 and type 2 diabetes.
Through its impact in the signaling of many cytokines such as types 1
& 2 IFNs, IL-6, IL-10, IL-12, IL-23, and probably others, TYK2 could be
associated to inﬂammatory and autoimmune diseases that involve a
disturbed production of these cytokines. However, due to the broad
potential effect of TYK2, its speciﬁc role in the pathogenesis of virus-,
and especially enterovirus-induced T1D remains an open issue.
Nagafuchi et al. (2015) claimed that the TYK2 promoter variant was
associatedwith amore signiﬁcant increased T1D risk in individualswith
ﬂu-like syndrome and in anti-GAD antibody-negative patients, but not
in those with positive anti-GAD antibody. This pattern of data suggests
that a TYK2 variant may be more likely associated with susceptibility
to virus-induced diabetes appearing as fulminant diabetes in human
beings, observed in Japan more frequently, rather than associated with
autoimmune T1D.
The relationship between TYK2 and EV-related autoimmune T1D
deserves further investigations. It cannot be excluded that TYK2
contributes to the pathogenesis of this disease, insofar as a strong
association was reported (Wallace et al., 2010). Considering that the
T1D risk allele leads to a reduced expression of TYK2 and a subsequent
decreased expression of type 1 IFN-induced genes, the overall result
would be a decreased antiviral response possibly involved in the mech-
anisms of virus persistence which canmaintain an inﬂammatory status.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
637E.K. Alidjinou, D. Hober / EBioMedicine 2 (2015) 636–637In conclusion, T1D is undoubtedly a multifactorial and polygenic
disease. The interaction between environmental insults such as EV
and innate immunity probably relies on a cross-talk between many
genes, which confers a susceptible background.
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